Analisi del mercato degli iniettori indossabili, dimensioni e portata entro il 2031
Wearable Injectors Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 8.98 Billion |
| Market Size by 2031 | US$ 21.61 Billion |
| Global CAGR (2023 - 2031) | 11.6% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered | By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
Market Players Density: Understanding Its Impact on Business Dynamics
The Wearable Injectors Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Wearable Injectors Market are:
- Amgen, Inc.
- Medtronic
- BD
- Insulet Corporation
- Gerresheimer AG (Sensile Medical)
- West Pharmaceutical Services, Inc.
Disclaimer
: The companies listed above are not ranked in any particular order.
- Get the Wearable Injectors Market top key players overview
Wearable Injectors Market News and Recent Developments
The wearable injectors market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for wearable injectors and strategies:
- Ypsomed enters a partnership with ten23 health, a global Swiss contract development and manufacturing organization. The aim of this collaboration is to advance the commercialization of the YpsoDose wearable injector for the subcutaneous self-injection of large-volume doses. ten23’s drug development, filling and device assembly expertise will significantly contribute to the product offering. (Source: Ypsomed Company Name, Press Release, 2024)
- Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions with reliable innovations that put patients at the center of care, is pleased to announce the successful completion of sale and transition of its wearable injectors business to LTS, a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems. The strategic acquisition marks a milestone for both organizations and sets the stage for further advancements in the field of patient-centric drug delivery systems. (Source: Eitan Medical Company Name, Newsletter, 2023)
Wearable Injectors Market Report Coverage and Deliverables
The “Wearable Injectors Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Get Free Sample For